Skip to content
Go To Homepage
  • Products
    • Oncology
    • Prenatal
  • Our Technology
    • Technology
    • Publications
  • Careers
    • Working with Us
    • Open Positions
  • News & Media
    • Press Releases
    • Media Coverage
    • Events
    • Social Media
  • About Us
    • Mission, Vision, Values
    • Leadership & Board
    • Company Milestones
  • Contact
abstract pattern of dots and lines

News & Media

Media Coverage

September 29, 2020

Swift Biosciences and BillionToOne Partner Together for Commercialization and Manufacturing of EUA Approved COVID-19 Test

Read

Media Coverage

September 8, 2020

BillionToOne secures EUA for RNA extraction-free Covid-19 test

Read

Media Coverage

September 8, 2020

BillionToOne, Sugentech Coronavirus Tests Get FDA Emergency Use Authorization

Read

Media Coverage

September 7, 2020

BillionToOne Granted FDA Emergency Use Authorization for Groundbreaking RNA Extraction-Free qSanger-COVID-19 Assay

Read

Media Coverage

April 14, 2020

Biocompare – BillionToOne to Offer Sanger Sequencing Based COVID-19 Test

Read

Media Coverage

April 13, 2020

New Coronavirus Protocol To Unlock A Million Daily Tests

Read

Follow Us

  • LinkedIn
  • Twitter

See Recent Social Posts

Social Posts

Get more news sent directly to your inbox.

Newsletter(Required)
This field is for validation purposes and should be left unchanged.
Go To Homepage

We are ONE team, working
toward ONE goal – to detect
disease ONE molecule at a time.

CAP Accredited College of American Pathologists

  • What We Offer
  • Our Technology
  • Publications
  • Products
  • Explore
  • News & Media
  • Press Releases
  • Media Coverage
  • Events
  • Social Media
  • About Us
  • Careers
  • Patient Portal
  • IT Security Compliance
  • Contact
  • Contact Information
  • Privacy Policy
  • Notice of Privacy Practices
  • Accessibility Statement
  • TERMS OF USE

ACCREDITATIONS UNION CITY: CA: 00353741 | CAP: 8643216 | CLIA: 05D2167800 | MD: 2999 | PA: 37021 | RI: LCO01671 | DC: OS29 | NYSDOH: 9828

ACCREDITATIONS MENLO PARK: CA: 90008579  | CAP: 9568790  | DC: OS43 | MD: 3855  | CLIA: 05D2275351  | RI: LCO01700  | PA: 40795

PATENT MARKINGS

© 2025 BillionToOne Inc.
All rights reserved.